{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:35:05Z","timestamp":1782369305154,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s10038-019-0600-x","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T05:02:30Z","timestamp":1555650150000},"page":"665-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1"],"prefix":"10.1038","volume":"64","author":[{"given":"Keiko","family":"Yamamoto-Shimojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-9610","authenticated-orcid":false,"given":"Tadashi","family":"Kaname","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-9272","authenticated-orcid":false,"given":"Yusuke","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9484-3505","authenticated-orcid":false,"given":"Toshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"600_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cge.12811","volume":"90","author":"A Charzewska","year":"2016","unstructured":"Charzewska A, Wierzba J, Izycka-Swieszewska E, Bekiesinska-Figatowska M, Jurek M, Gintowt A, et al. Hypomyelinating leukodystrophies-a molecular insight into the white matter pathology. Clin Genet. 2016;90:293\u2013304.","journal-title":"Clin Genet"},{"key":"600_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cga.12005","volume":"53","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T, Shimojima K. Pelizaeus-Merzbacher disease as a chromosomal disorder. Congenit Anom (Kyoto). 2013;53:3\u20138.","journal-title":"Congenit Anom (Kyoto)"},{"key":"600_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2013.04.017","volume":"330","author":"K Shimojima","year":"2013","unstructured":"Shimojima K, Tanaka R, Shimada S, Sangu N, Nakayama J, Iwasaki N, et al. A novel homozygous mutation of GJC2 derived from maternal uniparental disomy in a female patient with Pelizaeus-Merzbacher-like disease. J Neurol Sci. 2013;330:123\u20136.","journal-title":"J Neurol Sci"},{"key":"600_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.braindev.2014.05.004","volume":"37","author":"K Shimojima","year":"2015","unstructured":"Shimojima K, Okumura A, Ikeno M, Nishimura A, Saito A, Saitsu H, et al. A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease. Brain Dev. 2015;37:281\u20135.","journal-title":"Brain Dev"},{"key":"600_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1507\/endocrj.EJ17-0287","volume":"65","author":"H Sasaki","year":"2018","unstructured":"Sasaki H, Yanagi K, Ugi S, Kobayashi K, Ohkubo K, Tajiri Y, et al. Definitive diagnosis of mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome caused by a recurrent de novo mutation in the POLD1 gene. Endocr J. 2018;65:227\u201338.","journal-title":"Endocr J"},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jmoldx.2011.05.003","volume":"13","author":"B Bertelsen","year":"2011","unstructured":"Bertelsen B, Tumer Z, Ravn K. Three new loci for determining x chromosome inactivation patterns. J Mol Diagn. 2011;13:537\u201340.","journal-title":"J Mol Diagn"},{"key":"600_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.braindev.2012.07.010","volume":"35","author":"S Shimada","year":"2013","unstructured":"Shimada S, Okamoto N, Ito M, Arai Y, Momosaki K, Togawa M, et al. MECP2 duplication syndrome in both genders. Brain Dev. 2013;35:411\u20139.","journal-title":"Brain Dev"},{"key":"600_CR8","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1016\/j.bmcl.2011.07.053","volume":"21","author":"D Yu","year":"2011","unstructured":"Yu D, Sakurai F, Corey DR. Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. Bioorg Med Chem Lett. 2011;21:5202\u20135.","journal-title":"Bioorg Med Chem Lett"},{"key":"600_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/jhg.2012.71","volume":"57","author":"K Shimojima","year":"2012","unstructured":"Shimojima K, Inoue T, Imai Y, Arai Y, Komoike Y, Sugawara M, et al. Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication. J Hum Genet. 2012;57:580\u20136.","journal-title":"J Hum Genet"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.braindev.2015.12.002","volume":"38","author":"T Omata","year":"2016","unstructured":"Omata T, Nagai J, Shimbo H, Koizume S, Miyagi Y, Kurosawa K, et al. A splicing mutation of proteolipid protein 1 in Pelizaeus-Merzbacher disease. Brain Dev. 2016;38:581\u20134.","journal-title":"Brain Dev"},{"key":"600_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.1320550402","volume":"55","author":"ME Hodes","year":"1995","unstructured":"Hodes ME, DeMyer WE, Pratt VM, Edwards MK, Dlouhy SR. Girl with signs of Pelizaeus-Merzbacher disease heterozygous for a mutation in exon 2 of the proteolipid protein gene. Am J Med Genet. 1995;55:397\u2013401.","journal-title":"Am J Med Genet"},{"key":"600_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.ejhg.5200480","volume":"8","author":"K Woodward","year":"2000","unstructured":"Woodward K, Kirtland K, Dlouhy S, Raskind W, Bird T, Malcolm S, et al. X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations. Eur J Hum Genet. 2000;8:449\u201354.","journal-title":"Eur J Hum Genet"},{"key":"600_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.10036","volume":"50","author":"K Inoue","year":"2001","unstructured":"Inoue K, Tanaka H, Scaglia F, Araki A, Shaffer LG, Lupski JR. Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement. Ann Neurol. 2001;50:747\u201354.","journal-title":"Ann Neurol"},{"key":"600_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0883073808327833","volume":"24","author":"A Fattal-Valevski","year":"2009","unstructured":"Fattal-Valevski A, DiMaio MS, Hisama FM, Hobson GM, Davis-Williams A, Garbern JY, et al. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease. J Child Neurol. 2009;24:618\u201324.","journal-title":"J Child Neurol"},{"key":"600_CR15","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/mds.22734","volume":"24","author":"EM Yiu","year":"2009","unstructured":"Yiu EM, Farrell SA, Soman T. Classic Pelizaeus-Merzbacher disease in a girl with an unbalanced chromosomal translocation and functional duplication of PLP1. Mov Disord. 2009;24:2171\u20132.","journal-title":"Mov Disord"},{"key":"600_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1399-0004.2011.01716.x","volume":"81","author":"CM Carvalho","year":"2012","unstructured":"Carvalho CM, Bartnik M, Pehlivan D, Fang P, Shen J, Lupski JR. Evidence for disease penetrance relating to CNV size: Pelizaeus-Merzbacher disease and manifesting carriers with a familial 11 Mb duplication at Xq22. Clin Genet. 2012;81:532\u201341.","journal-title":"Clin Genet"},{"key":"600_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1399-0004.2012.01854.x","volume":"83","author":"AC Fonseca","year":"2013","unstructured":"Fonseca AC, Bonaldi A, Costa SS, Freitas MR, Kok F, Vianna-Morgante AM. PLP1 duplication at the breakpoint regions of an apparently balanced t(X;22) translocation causes Pelizaeus-Merzbacher disease in a girl. Clin Genet. 2013;83:169\u201374.","journal-title":"Clin Genet"},{"key":"600_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pediatrneurol.2013.07.012","volume":"49","author":"M Matsufuji","year":"2013","unstructured":"Matsufuji M, Osaka H, Gotoh L, Shimbo H, Takashima S, Inoue K. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2. Pedia Neurol. 2013;49:477\u201381.","journal-title":"Pedia Neurol"},{"key":"600_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0883073813492387","volume":"29","author":"P Lassuthova","year":"2014","unstructured":"Lassuthova P, Zaliova M, Inoue K, Haberlova J, Sixtova K, Sakmaryova I, et al. Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease. J Child Neurol. 2014;29:924\u201331.","journal-title":"J Child Neurol"},{"key":"600_CR20","first-page":"453105","volume":"2015","author":"T Brender","year":"2015","unstructured":"Brender T, Wallerstein D, Sum J, Wallerstein R. Unusual presentation of pelizaeus-merzbacher disease: female patient with deletion of the proteolipid protein 1 gene. Case Rep Genet. 2015;2015:453105.","journal-title":"Case Rep Genet"},{"key":"600_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0226-6","volume":"16","author":"J Masliah-Planchon","year":"2015","unstructured":"Masliah-Planchon J, Dupont C, Vartzelis G, Trimouille A, Eymard-Pierre E, Gay-Bellile M, et al. Insertion of an extra copy of Xq22.2 into 1p36 results in functional duplication of the PLP1 gene in a girl with classical Pelizaeus-Merzbacher disease. BMC Med Genet. 2015;16:77.","journal-title":"BMC Med Genet"},{"key":"600_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-004-0207-y","volume":"6","author":"K Inoue","year":"2005","unstructured":"Inoue K. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics. 2005;6:1\u201316.","journal-title":"Neurogenetics"},{"key":"600_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ng1322","volume":"36","author":"K Inoue","year":"2004","unstructured":"Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet. 2004;36:361\u20139.","journal-title":"Nat Genet"},{"key":"600_CR24","doi-asserted-by":"publisher","first-page":"12591","DOI":"10.1073\/pnas.1413620111","volume":"111","author":"S Bhatnagar","year":"2014","unstructured":"Bhatnagar S, Zhu X, Ou J, Lin L, Chamberlain L, Zhu LJ, et al. Genetic and pharmacological reactivation of the mammalian inactive X chromosome. Proc Natl Acad Sci USA. 2014;111:12591\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"600_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-015-0034-4","volume":"8","author":"A Minkovsky","year":"2015","unstructured":"Minkovsky A, Sahakyan A, Bonora G, Damoiseaux R, Dimitrova E, Rubbi L, et al. A high-throughput screen of inactive X chromosome reactivation identifies the enhancement of DNA demethylation by 5-aza-2\u2019-dC upon inhibition of ribonucleotide reductase. Epigenetics Chromatin. 2015;8:42.","journal-title":"Epigenetics Chromatin"},{"key":"600_CR26","doi-asserted-by":"publisher","first-page":"14366","DOI":"10.1073\/pnas.1617597113","volume":"113","author":"D Lessing","year":"2016","unstructured":"Lessing D, Dial TO, Wei C, Payer B, Carrette LL, Kesner B, et al. A high-throughput small molecule screen identifies synergism between DNA methylation and Aurora kinase pathways for X reactivation. Proc Natl Acad Sci USA. 2016;113:14366\u201371.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0600-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0600-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:20Z","timestamp":1684616840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-019-0600-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1038\/s10038-019-0600-x","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"7 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}